Literature DB >> 6716538

Effect of measles on the nutritional status of preschool children.

P Bhaskaram, V Reddy, S Raj, R C Bhatnagar.   

Abstract

A total of 1426 children admitted to the hospital for measles were studied. Of these, 84 were followed up for a period of 6 months after they were discharged from the hospital. It was observed that about 23% of the cases developed secondary infection during the acute stage of measles. Diarrhoea and respiratory infection were the common complications. Some children developed corneal lesions during the acute stage. Serum vitamin A levels were significantly low in these children and they showed a good clinical response to vitamin A therapy. During the follow-up period the children suffered from frequent episodes of infections for nearly 6 months after the attack of measles and the weight gain was significantly lower compared to normal children. These observations suggest that measles plays a significant role in precipitation of malnutrition and blindness due to vitamin A deficiency in preschool children.

Entities:  

Mesh:

Year:  1984        PMID: 6716538

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  5 in total

Review 1.  Antibiotics for preventing complications in children with measles.

Authors:  Sushil K Kabra; Rakesh Lodha
Journal:  Cochrane Database Syst Rev       Date:  2013-08-14

2.  Interaction between nutrition and measles.

Authors:  V Reddy
Journal:  Indian J Pediatr       Date:  1987 Jan-Feb       Impact factor: 1.967

Review 3.  Infections and malnutrition among poor children.

Authors:  P Bhaskaram
Journal:  Indian J Pediatr       Date:  1987 Jul-Aug       Impact factor: 1.967

Review 4.  Measles immunization research: a review.

Authors:  P Aaby; C J Clements
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

5.  Decomposing the gap in childhood undernutrition between poor and non-poor in urban India, 2005-06.

Authors:  Abhishek Kumar; Aditya Singh
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.